An ongoing dialogue on HIV/AIDS, infectious diseases,
December 24th, 2013
Brush with Greatness: John G. Bartlett
At the IDSA meeting in 2012, John Bartlett gave a lecture called, “Infectious Diseases Update for the HIV Provider” — what a great title — which was, as usual, information-packed, practical, well-referenced, and just plain fun. It also occurred to me at the time that there is probably no other person on the planet who could give this lecture, and made me vow to write something about what a treat it is chatting with John at ID meetings or other events.
For those of you who don’t keep up with the celebrities in Infectious Diseases, John was Chief of the Division of Infectious Diseases at Johns Hopkins for 26 years, stepping down in 2006. He was also the Co-Chair and one of the founding members of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, a position that we’ve just learned he is leaving this year.
But John is much, much more than these titles. John is the true Renaissance Man of Infectious Diseases, the person in our field who somehow seems to know something — and usually a lot of something — about everything.
You want some examples? How many ID doctors are true experts in all of the following distinct topics?
- HIV
- Clostridium difficile
- Respiratory tract infections
- Antimicrobial resistance
- Anaerobic pulmonary infections
I’m fairly certain the answer is “Just one — John Bartlett”, and I’m no doubt doing him a disservice by leaving off several other areas of expertise that should be added to the list. Most of us ID doctors would make a career out of one of these topics.
The other impressive thing about John is that he’s a true visionary. Says his long-time former colleague Joel Gallant:
John is a man of incredible vision. He always knows what the next big thing will be, and embraces it long before it becomes the next big thing. There are many examples: managed care, bioterrorism, medical education on the internet (before he knew how to turn on his own computer), pandemic flu, and of course HIV/AIDS. Back when most hospitals, university medical centers, and ID divisions were running away from the AIDS epidemic, John took it on, both as a scientific priority and a moral imperative. With the help of Frank Polk and the Hopkins president, he established an outpatient AIDS clinic and an inpatient AIDS ward—both of which were way ahead of their time.
This last part is well worth reading again, which is why I bolded it. To start an HIV program at Hopkins in the 1980s was a truly brave move; many hospital administrators (possibly at Hopkins and definitely elsewhere — ahem, looking at you one particular Harvard hospital) strongly opposed opening HIV clinics or inpatient services, as they feared the stigma such a clinical and research focus would bring to their institutions. John discusses these early days in more detail here.
Finally, is there a person better at combining both the practical and the scholarly aspects of Infectious Diseases than John G. Bartlett? And someone who does it with such excitement? Not a chance — think of his numerous guidebooks … his “Game Changers” or “Hot Topics in ID” lectures at IDSA … his end-of-the-year summaries (here’s a good one for 2013, didn’t know there was a Mimivirus!) … his “Awards”, such as this one for most important bacterium, of all things.
You can just sense how fascinating he finds each of these topics, and that enthusiasm inevitably makes us excited too — a key quality of a great teacher.
John will be missed on the Guidelines panel, but we will always know where to find him at our ID meetings — sitting toward the front at a major plenary session, taking careful notes in longhand on a large yellow pad.
Hey, he doesn’t want to miss anything!
(One in a very occasional series.)
Categories: Health Care, HIV, Infectious Diseases, Medical Education, Patient Care, Research
Tags: Brush with Greatness, HIV, John Bartlett, Johns Hopkins
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
3 Responses to “Brush with Greatness: John G. Bartlett”

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing
- Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country
- Sometimes You Just Need to Get Input from a Real Human Being
- Mystifying Abbreviations — Infectious Diseases Edition
- Rabies Is Terrifying — and the Challenge of Managing a Low Risk of a Dreadful Disease
-
From the Blog — Most Recent Articles
- Some Ruminations on CROI — Still the Best HIV Meeting February 26, 2026
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing February 17, 2026
- Sometimes You Just Need to Get Input from a Real Human Being February 12, 2026
- Mystifying Abbreviations — Infectious Diseases Edition February 4, 2026
- Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country January 27, 2026
FROM NEJM — Recent Infectious Disease Articles- Primary Measles Infection February 26, 2026A previously healthy man presented with a 5-day history of fever, nausea, and vomiting and a 2-day history of an itchy rash. Examination showed an exanthem consisting of minute macules and subtly elevated papules.
- Tecovirimat for the Treatment of Mpox February 26, 2026Mpox continues to spread in many communities. Tecovirimat has activity against orthopoxviruses in vitro. In a phase 3 trial involving patients with acute mpox, tecovirimat showed no evidence of clinical activity.
- Microbial Flora in War Wounds from the Ukrainian Front Line February 26, 2026Battlefield injuries are often contaminated with potentially infecting microbes. In this study, swabs obtained in the field after injury were profiled. Microbes and potential antimicrobial-resistance genes were characterized.
- AI-Enabled Precision-Education Systems — Transforming Lifelong Learning in Medicine February 26, 2026Trainees’ paths to safe, independent practice are variable. Artificial intelligence could help accelerate implementation of competency-based medical education to support individualized development.
- From Efficacy to Access in Long-Acting HIV Therapy February 26, 2026Over the past three decades, advances in antiretroviral therapy (ART) have dramatically improved life expectancy, decreased frailty, and improved quality of life for persons with human immunodeficiency virus (HIV).1,2 These gains have accrued primarily among those who can reliably access health care and adhere to daily treatment. For...
- Primary Measles Infection February 26, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster

Dr. Bartlett is one of the Great Ones. He was already well known for anaerobic pulmonary infections in 1972 when I was a fellow in ID at Baylor. It is an inspiration to see guys like that retaining their passion.
Thanks for cluing me, a non-ID person, into Dr. Bartlett’s accessible writing. I will be looking for more of his work!
One of the greats for sure. I had the honor to work with him for nine years. A mentor and good example for us all.